Gender differences and antioxidant treatment affect aortic reactivity in short-term diabetic rats

European Journal of Pharmacology

Volumn 431, Issue 1, 2001, Pages 71-79

  Pinna, Christian ^a   Cignarella, Andrea ^a   Zanardo, Rossella ^a   Bolego, Chiara ^a   Puglisi, Lina ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Antioxidant; Aorta; Diabetes; Lercanidipine; Leucoselect; Nitric oxide (NO)

Indexed keywords

ACETYLCHOLINE; ANTIOXIDANT; ILOPROST; LERCANIDIPINE; LEUCOSELECT; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITROPRUSSIDE SODIUM; NORADRENALIN; SHL 401; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTERY DILATATION; ARTICLE; BLOOD VESSEL INJURY; BLOOD VESSEL REACTIVITY; BLOOD VESSEL WALL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIABETIC ANGIOPATHY; DRUG EFFECT; DRUG SENSITIVITY; FEMALE; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SEX DIFFERENCE; STREPTOZOCIN DIABETES; THORACIC AORTA;

ACETYLCHOLINE; ANIMALS; ANTIOXIDANTS; AORTA, THORACIC; BLOOD GLUCOSE; DIABETES MELLITUS; DIABETES MELLITUS, EXPERIMENTAL; DIHYDROPYRIDINES; FEMALE; ILOPROST; MALE; MUSCLE, SMOOTH, VASCULAR; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE DONORS; NITROPRUSSIDE; NOREPINEPHRINE; RATS; SEX FACTORS; SUPEROXIDE DISMUTASE; VASOCONSTRICTION; VASODILATOR AGENTS;

EID: 0035834528     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(01)01416-9     Document Type: Article

References (44)

1. Vascular-selective effect of lercanidipine and other 1,4-dihydropyridines in isolated rabbit tissues
2. Estrogen and coronary heart disease in women
3. Differential effects of low- and high-dose estrogen treatments on vascular responses in female rats
4. Diabetes abolishes the vascular protective effects of estrogen in female rats
5. Modification of vasodilator response in streptozotocin-induced diabetic rat
6. Antiatherosclerotic activity of drugs in relation to nitric oxide function
7. Lipid-derived autacoids, eicosanoids and platelet-activating factor
8. Pressure and microcirculatory effects of treatment with lercanidipine in hypertensive patients and in vascular patients with hypertension
9. Stimulation of prostaglandin cyclooxygenase and prostacyclin synthase activities by estradiol in rat aortic smooth muscle cells
10. Effect of the new calcium antagonist lercanidipine and its enantiomers on the migration and proliferation of arterial myocytes
11. Antioxidants and atherosclerotic heart disease
12. Reactive oxygen species and antioxidant status in essential arterial hypertension during therapy with dihydropyridine calcium channel antagonists
13. Peripheral diabetic neuropathy - Current recommendation and future prospects for its prevention and management
14. Vascular responsiveness in young, diabetic, and aging hyperinsulinemic rats
15. Effect of glucose and insulin on release of prostaglandins from the mesenteric vascular bed in control and streptozotocin diabetic animals
16. Cardiovascular disease in patients with diabetes: Clinical considerations
17. Characterization of proanthocyanidins from grape seeds
18. Morbidity and mortality in diabetics in the Framingham population: Sixteen-year follow-up study
19. Oxidative stress and diabetic vascular complications
20. Pharmacological in vitro studies of the new 1, 4-dihydropyridine calcium antagonist lercanidipine
21. Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: Implications for atherosclerosis
22. Gender differences in atherosclerosis., possible role of nitric oxide
23. Dehydroepiandrosterone retards atherosclerosis formation through its conversion to estrogen: The possible role of nitric oxide
24. Dietary antioxidant flavonoids and risk of coronary heart disease: The Zutphen elderly study
25. Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus
26. Repeated measurements and multiple comparisons in cardiovascular research
27. Protection by shear stress from collar-induced intimal thickening: Role of nitric oxide
28. Role of vascular nitric oxide in physiological and pathological conditions
29. 2 release. Prostaglandins Leukotrienes Essent
30. Fruit and vegetables, and cardiovascular disease: A review
31. An evaluation of the antioxidant activity of a standardized grape seed extract, Leucoselect™
32. Glucose inhibits prostacyclin production by cultured aortic endothelial cells
33. Effects of experimental diabetes and insulin on smooth muscle functions
34. Diabetic-induced endothelial dysfunction in rat aorta: Role of hydroxyl radicals
35. Impairment of endothelium dependent relaxation in the diabetic rat heart: Mechanisms and implications
36. Atherosclerosis - An inflammatory disease
37. Effect of lercanidipine and its R-enantiomer on atherosclerotic lesions induced in hypercholesterolemic rabbits
38. Diabetes mellitus and cardiovascular disease in women
39. Vitamin E consumption and the risk of coronary disease in women
40. Free radicals in diabetic endothelial cell dysfunction
41. Optimization of nutrition, polyphenols and vascular protection
42. 2) by vascular tissue
43. Paracrine role of adventitial superoxide anion in mediating spontaneous tone of the isolated rat aorta in angiotensin II-induced hypertension
44. Pranidipine enhances the action of nitric oxide released from endothelial cells